Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition.
about
A novel GRK2/HDAC6 interaction modulates cell spreading and motilityThe protein farnesyltransferase regulates HDAC6 activity in a microtubule-dependent mannerMechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionRole of HIPK2 in kidney fibrosisFunctions of lncRNA HOTAIR in lung cancerGenomic impact of cigarette smoke, with application to three smoking-related diseasesInduction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen.Interaction of Src and Alpha-V Integrin Regulates Fibroblast Migration and Modulates Lung Fibrosis in A Preclinical Model of Lung FibrosisMAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal Transition.The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression.Effect of EGF-induced HDAC6 activation on corneal epithelial wound healingArsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesisModulation of lung inflammation by the Epstein-Barr virus protein Zta.Histone deacetylase 1 and 2 differentially regulate apoptosis by opposing effects on extracellular signal-regulated kinase 1/2HDAC6 deacetylase activity is required for hypoxia-induced invadopodia formation and cell invasion.The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulationHistone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells.Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by SilicaQuantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation.Connecting the dots: chromatin and alternative splicing in EMT.Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal TransitionRegulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiationLung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigeneticsProteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotypeHistone deacetylase inhibitors as novel anticancer therapeutics.HDAC6 regulates neuroblastoma cell migration and may play a role in the invasion process.Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells.Down-regulation of Krüppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-β1.Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cellsImmunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.Comparative profiling of miRNA expression of lung adenocarcinoma cells in two-dimensional and three-dimensional cultures.The microRNA expression associated with morphogenesis of breast cancer cells in three-dimensional organotypic culture.Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.Role of Smads in TGFβ signaling.Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: an update.
P2860
Q24300454-9D46AD07-1B17-4B7F-BE74-AD1D44514535Q24312194-D2B2C742-9025-49C6-A5B1-2B04F5FC4C75Q26745545-F836C934-6D20-4BA7-8E9B-47251A3DC983Q26796620-4B4F1342-B533-4C01-A50A-7513995F4D6FQ26849432-985E734E-F954-488B-930A-8053FD6B7B21Q27027763-305B7339-8757-4F2C-8AB1-39451E93A579Q30625242-B3D1AEFB-BC26-46D1-9368-301AE29F4E24Q33551808-23159AB1-E292-42F5-9385-737718325ADEQ33870212-9667BAAA-C558-4CB4-8AD3-3D00C844140AQ33934350-356D21F2-FB8F-4F40-A7A5-4FE99B9CAFDAQ33938181-CE005B3B-A1E5-4260-90DE-76E9D48EF839Q33960458-912D4D26-0A2C-43F8-9A38-46DD1A7DE18BQ34004676-BF39768D-F96D-4AB2-9783-594387043FC8Q34426098-510470BF-351E-4625-970C-F13874C12AB7Q34545336-AE634B15-09C2-4175-A2FE-FD02CC5507F9Q34584292-B12B4401-690E-4B00-812A-34AF03E02F25Q34984418-32ACF231-849A-4E1B-A2D2-A8BD955325C2Q35300659-288A5F54-5D27-4DE9-83B7-2680081B916CQ35357827-193FDB84-1BC5-4905-94E4-2E959512A380Q35470183-D87A56DD-0B53-4F6A-9B89-913659C35650Q36117802-D201C3F3-FEC0-471D-BCB9-08C8B5DFEF81Q36274229-5E484D8F-90FD-4D3D-B479-5D2B5B17B1EBQ36441240-7119576D-A4C1-4BC3-8415-68E823ABEF32Q36499388-F4CEF3A9-4016-4306-8C48-17CF02E0214AQ36650414-BAA6CDB7-5693-4509-83BE-F67233FC209AQ36664232-5C1FAC96-806A-4DAB-9975-08089A3EBFE1Q37062105-B1D6B53F-DDB8-4A86-BB33-9866A0A6C2B1Q37131365-DFC07865-8383-46FC-89E9-AD9ED4062340Q37325492-321E8688-3FD2-48C6-A4EA-2A39619D2B83Q37420201-B63B6185-C1CC-495A-82D7-F27AED9A78FFQ37421300-2548DDEB-8417-49DA-A26E-744E2AB00F0BQ37466825-88669628-4C2C-48CF-A2CF-CAD9C07304DBQ37520619-988CAB63-4555-4288-A79E-736FD71DE3E9Q37588310-4B341FE7-A4B8-443E-9D57-00CB898B05CDQ37621254-6E0F598E-4A26-4557-BE68-0A0E0E665A09Q37672479-1167AB7E-5AB5-4770-9E2C-C6DF40AFC6FDQ37709541-48DDEA7C-66F7-417B-806F-3B3D42DCF752Q37735806-346AC729-7548-44C1-972D-3446DEC28765Q37885217-626BF3F2-8247-418B-A1A6-EAADECD3E6CEQ38008698-3315DFFE-E905-448D-A62F-4B2805C24EDD
P2860
Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Requirement of HDAC6 for trans ...... helial-mesenchymal transition.
@ast
Requirement of HDAC6 for trans ...... helial-mesenchymal transition.
@en
type
label
Requirement of HDAC6 for trans ...... helial-mesenchymal transition.
@ast
Requirement of HDAC6 for trans ...... helial-mesenchymal transition.
@en
prefLabel
Requirement of HDAC6 for trans ...... helial-mesenchymal transition.
@ast
Requirement of HDAC6 for trans ...... helial-mesenchymal transition.
@en
P2093
P2860
P356
P1476
Requirement of HDAC6 for trans ...... thelial-mesenchymal transition
@en
P2093
Dawn R Levy
Hong T Nguyen
Joseph A Lasky
Kevin N Holder
Michael L Palmer
Ross C Klingsberg
Tso-pang Yao
P2860
P304
21065-21073
P356
10.1074/JBC.M802786200
P407
P50
P577
2008-05-21T00:00:00Z